Neogen Corporation (NEOG)
Nasdaq: NEOG · In Vitro & In Vivo Diagnostic Substances · Lansing, MI · filing with the SEC since 1995
Grade5.5
◀ Past 6.3● Present 5.8▶ Future 4.3
Who owns Neogen Corporation
As filed with the SECHolders of 5% or more
4
Blackrock, Inc. holds 14.3% of Common Stock, as its SCHEDULE 13G/A filed Apr 24, 2025 says.
Directors and officers
23
report now, of 37 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 24, 2025 · Common Stock
Neuberger Berman Group LLC
SCHEDULE 13G · filed Jul 7, 2026 · Common
Vanguard Portfolio Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
Baillie Gifford & Co
SCHEDULE 13G/A · filed Feb 12, 2025 · Common Stock · reported falling below 5%, from 5.2% in Nov 4, 2024
William Blair Investment Management, LLC
SCHEDULE 13G/A · filed Jul 30, 2025 · Common Stock · reported falling below 5%
Select Equity Group, L.P.
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock · reported falling below 5%
Norges Bank
SCHEDULE 13G/A · filed Jul 24, 2025 · Common Stock · reported falling below 5%, from 6.8% in Apr 10, 2025
ING Groep N.V.
SCHEDULE 13G/A · filed Dec 4, 2025 · Common Stock, $0.16 par value per share · reported falling below 5%, from 6.47% in Oct 22, 2025
Gates Capital Management, L.P.
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, $0.16 par value per share · reported falling below 5%, from 5.9% in Aug 14, 2025
Clarkston Capital Partners, LLC
SCHEDULE 13G/A · filed May 14, 2026 · Common Stock · reported falling below 5%, from 5.38% in Nov 13, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 10.8% in Apr 7, 2025
What NEOG reports owning in othersstakes of 5% or more, and other ties
50 subsidiaries in 23 countries, from the list filed with the 10-K filed Jul 30, 2026.
Insider tradesForm 4
1sales
6purchases
0sales on a scheduled plan
1people selling
$100,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 4, 2025 to Nov 4, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 4, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 37 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Yarwood Jeremy | Chief Scientific Officer | 1 | $100,000 | 0 | 0 | $0 |
| Nassif Mikheal | CEO | 0 | $0 | 0 | 6 | $0 |